ABBOTT ULTANE INHALATION ANESTHETIC SHIPMENTS TO BEGIN BY END OF JUNE; PHASE IV NEPHROTOXICITY STUDIES TO FOCUS ON COMPOUND A, LOW GAS FLOW RATES